nodes	percent_of_prediction	percent_of_DWPC	metapath
Vildagliptin—DPP9—mammary gland—sarcoma	0.113	0.225	CbGeAlD
Vildagliptin—DPP9—tendon—sarcoma	0.0456	0.0906	CbGeAlD
Vildagliptin—DPP9—testis—sarcoma	0.0377	0.0751	CbGeAlD
Vildagliptin—DPP9—liver—sarcoma	0.0357	0.071	CbGeAlD
Vildagliptin—DPP4—embryo—sarcoma	0.0295	0.0587	CbGeAlD
Vildagliptin—DPP4—seminal vesicle—sarcoma	0.0277	0.0551	CbGeAlD
Vildagliptin—DPP9—lymph node—sarcoma	0.0273	0.0544	CbGeAlD
Vildagliptin—DPP4—hematopoietic system—sarcoma	0.0263	0.0524	CbGeAlD
Vildagliptin—DPP4—connective tissue—sarcoma	0.0253	0.0504	CbGeAlD
Vildagliptin—DPP4—smooth muscle tissue—sarcoma	0.0232	0.0461	CbGeAlD
Vildagliptin—DPP4—uterus—sarcoma	0.0199	0.0396	CbGeAlD
Vildagliptin—DPP4—lymphoid tissue—sarcoma	0.0185	0.0369	CbGeAlD
Vildagliptin—DPP4—tendon—sarcoma	0.0174	0.0347	CbGeAlD
Vildagliptin—DPP4—bone marrow—sarcoma	0.0169	0.0336	CbGeAlD
Vildagliptin—DPP4—testis—sarcoma	0.0144	0.0287	CbGeAlD
Vildagliptin—DPP4—liver—sarcoma	0.0136	0.0271	CbGeAlD
Vildagliptin—Skin exfoliation—Thiotepa—sarcoma	0.0114	0.0229	CcSEcCtD
Vildagliptin—DPP4—lymph node—sarcoma	0.0105	0.0208	CbGeAlD
Vildagliptin—Skin exfoliation—Etoposide—sarcoma	0.00818	0.0164	CcSEcCtD
Vildagliptin—Liver function test abnormal—Dactinomycin—sarcoma	0.00793	0.0159	CcSEcCtD
Vildagliptin—Weight increased—Thiotepa—sarcoma	0.00681	0.0137	CcSEcCtD
Vildagliptin—Infestation NOS—Thiotepa—sarcoma	0.00667	0.0134	CcSEcCtD
Vildagliptin—Infestation—Thiotepa—sarcoma	0.00667	0.0134	CcSEcCtD
Vildagliptin—Blister—Epirubicin—sarcoma	0.00666	0.0134	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Thiotepa—sarcoma	0.00631	0.0127	CcSEcCtD
Vildagliptin—Blister—Doxorubicin—sarcoma	0.00617	0.0124	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Mitoxantrone—sarcoma	0.00601	0.0121	CcSEcCtD
Vildagliptin—Hepatitis—Dactinomycin—sarcoma	0.00594	0.012	CcSEcCtD
Vildagliptin—Connective tissue disorder—Thiotepa—sarcoma	0.00589	0.0118	CcSEcCtD
Vildagliptin—Weight increased—Mitoxantrone—sarcoma	0.00588	0.0118	CcSEcCtD
Vildagliptin—Angiopathy—Thiotepa—sarcoma	0.00543	0.0109	CcSEcCtD
Vildagliptin—Chills—Thiotepa—sarcoma	0.00537	0.0108	CcSEcCtD
Vildagliptin—Chills—Dactinomycin—sarcoma	0.00533	0.0107	CcSEcCtD
Vildagliptin—Connective tissue disorder—Vincristine—sarcoma	0.00522	0.0105	CcSEcCtD
Vildagliptin—Malnutrition—Thiotepa—sarcoma	0.00521	0.0105	CcSEcCtD
Vildagliptin—Hepatitis—Mitoxantrone—sarcoma	0.00517	0.0104	CcSEcCtD
Vildagliptin—Angiopathy—Vincristine—sarcoma	0.00482	0.00969	CcSEcCtD
Vildagliptin—Infestation—Etoposide—sarcoma	0.00479	0.00964	CcSEcCtD
Vildagliptin—Infestation NOS—Etoposide—sarcoma	0.00479	0.00964	CcSEcCtD
Vildagliptin—Chills—Mitoxantrone—sarcoma	0.00464	0.00933	CcSEcCtD
Vildagliptin—Skin exfoliation—Epirubicin—sarcoma	0.00459	0.00922	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Etoposide—sarcoma	0.00453	0.00911	CcSEcCtD
Vildagliptin—Arthralgia—Thiotepa—sarcoma	0.00444	0.00892	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—sarcoma	0.00441	0.00886	CcSEcCtD
Vildagliptin—Skin exfoliation—Doxorubicin—sarcoma	0.00424	0.00853	CcSEcCtD
Vildagliptin—Infection—Thiotepa—sarcoma	0.00423	0.0085	CcSEcCtD
Vildagliptin—Oedema—Dactinomycin—sarcoma	0.00422	0.00849	CcSEcCtD
Vildagliptin—Infection—Dactinomycin—sarcoma	0.0042	0.00844	CcSEcCtD
Vildagliptin—Nervous system disorder—Thiotepa—sarcoma	0.00417	0.00839	CcSEcCtD
Vildagliptin—Skin disorder—Thiotepa—sarcoma	0.00413	0.00831	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Epirubicin—sarcoma	0.00399	0.00802	CcSEcCtD
Vildagliptin—Angiopathy—Etoposide—sarcoma	0.0039	0.00785	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Thiotepa—sarcoma	0.00388	0.00779	CcSEcCtD
Vildagliptin—Chills—Etoposide—sarcoma	0.00386	0.00776	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.00385	0.00774	CcSEcCtD
Vildagliptin—Arthralgia—Mitoxantrone—sarcoma	0.00383	0.00771	CcSEcCtD
Vildagliptin—Oedema—Vincristine—sarcoma	0.00377	0.00759	CcSEcCtD
Vildagliptin—Infection—Vincristine—sarcoma	0.00375	0.00754	CcSEcCtD
Vildagliptin—Nervous system disorder—Vincristine—sarcoma	0.0037	0.00744	CcSEcCtD
Vildagliptin—Hepatic function abnormal—Doxorubicin—sarcoma	0.00369	0.00742	CcSEcCtD
Vildagliptin—Oedema—Mitoxantrone—sarcoma	0.00367	0.00739	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Thiotepa—sarcoma	0.00367	0.00739	CcSEcCtD
Vildagliptin—Fatigue—Thiotepa—sarcoma	0.00367	0.00738	CcSEcCtD
Vildagliptin—Infection—Mitoxantrone—sarcoma	0.00365	0.00734	CcSEcCtD
Vildagliptin—Hyperhidrosis—Vincristine—sarcoma	0.00365	0.00733	CcSEcCtD
Vildagliptin—Dermatitis bullous—Epirubicin—sarcoma	0.00365	0.00733	CcSEcCtD
Vildagliptin—Fatigue—Dactinomycin—sarcoma	0.00364	0.00732	CcSEcCtD
Vildagliptin—Constipation—Thiotepa—sarcoma	0.00364	0.00732	CcSEcCtD
Vildagliptin—Hypoglycaemia—Epirubicin—sarcoma	0.00357	0.00718	CcSEcCtD
Vildagliptin—Skin disorder—Mitoxantrone—sarcoma	0.00357	0.00718	CcSEcCtD
Vildagliptin—Hyperhidrosis—Mitoxantrone—sarcoma	0.00355	0.00714	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Vincristine—sarcoma	0.00344	0.00691	CcSEcCtD
Vildagliptin—Urticaria—Thiotepa—sarcoma	0.00338	0.0068	CcSEcCtD
Vildagliptin—Dermatitis bullous—Doxorubicin—sarcoma	0.00338	0.00679	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.00335	0.00673	CcSEcCtD
Vildagliptin—Hypoglycaemia—Doxorubicin—sarcoma	0.00331	0.00665	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Vincristine—sarcoma	0.00326	0.00655	CcSEcCtD
Vildagliptin—Fatigue—Vincristine—sarcoma	0.00325	0.00654	CcSEcCtD
Vildagliptin—Constipation—Vincristine—sarcoma	0.00323	0.00649	CcSEcCtD
Vildagliptin—Liver function test abnormal—Epirubicin—sarcoma	0.00322	0.00647	CcSEcCtD
Vildagliptin—Fatigue—Mitoxantrone—sarcoma	0.00317	0.00637	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.00317	0.00637	CcSEcCtD
Vildagliptin—Constipation—Mitoxantrone—sarcoma	0.00314	0.00632	CcSEcCtD
Vildagliptin—Nasopharyngitis—Epirubicin—sarcoma	0.00312	0.00627	CcSEcCtD
Vildagliptin—Asthenia—Thiotepa—sarcoma	0.00305	0.00614	CcSEcCtD
Vildagliptin—Infection—Etoposide—sarcoma	0.00304	0.00611	CcSEcCtD
Vildagliptin—Asthenia—Dactinomycin—sarcoma	0.00303	0.00609	CcSEcCtD
Vildagliptin—Liver function test abnormal—Doxorubicin—sarcoma	0.00298	0.00599	CcSEcCtD
Vildagliptin—Skin disorder—Etoposide—sarcoma	0.00297	0.00597	CcSEcCtD
Vildagliptin—Hyperhidrosis—Etoposide—sarcoma	0.00296	0.00594	CcSEcCtD
Vildagliptin—Pancreatitis—Epirubicin—sarcoma	0.00295	0.00594	CcSEcCtD
Vildagliptin—Urticaria—Mitoxantrone—sarcoma	0.00292	0.00587	CcSEcCtD
Vildagliptin—Diarrhoea—Thiotepa—sarcoma	0.00291	0.00585	CcSEcCtD
Vildagliptin—Diarrhoea—Dactinomycin—sarcoma	0.00289	0.00581	CcSEcCtD
Vildagliptin—Nasopharyngitis—Doxorubicin—sarcoma	0.00288	0.0058	CcSEcCtD
Vildagliptin—Dizziness—Thiotepa—sarcoma	0.00281	0.00566	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Epirubicin—sarcoma	0.0028	0.00563	CcSEcCtD
Vildagliptin—Weight increased—Epirubicin—sarcoma	0.00274	0.00551	CcSEcCtD
Vildagliptin—Pancreatitis—Doxorubicin—sarcoma	0.00273	0.0055	CcSEcCtD
Vildagliptin—Asthenia—Vincristine—sarcoma	0.00271	0.00544	CcSEcCtD
Vildagliptin—Infestation—Epirubicin—sarcoma	0.00269	0.0054	CcSEcCtD
Vildagliptin—Infestation NOS—Epirubicin—sarcoma	0.00269	0.0054	CcSEcCtD
Vildagliptin—Headache—Thiotepa—sarcoma	0.00267	0.00536	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Etoposide—sarcoma	0.00264	0.00531	CcSEcCtD
Vildagliptin—Asthenia—Mitoxantrone—sarcoma	0.00264	0.0053	CcSEcCtD
Vildagliptin—Fatigue—Etoposide—sarcoma	0.00264	0.0053	CcSEcCtD
Vildagliptin—Constipation—Etoposide—sarcoma	0.00261	0.00526	CcSEcCtD
Vildagliptin—Upper respiratory tract infection—Doxorubicin—sarcoma	0.00259	0.00521	CcSEcCtD
Vildagliptin—Diarrhoea—Vincristine—sarcoma	0.00258	0.00519	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Epirubicin—sarcoma	0.00254	0.00511	CcSEcCtD
Vildagliptin—Weight increased—Doxorubicin—sarcoma	0.00254	0.0051	CcSEcCtD
Vildagliptin—Nausea—Thiotepa—sarcoma	0.00253	0.00508	CcSEcCtD
Vildagliptin—Diarrhoea—Mitoxantrone—sarcoma	0.00251	0.00505	CcSEcCtD
Vildagliptin—Nausea—Dactinomycin—sarcoma	0.00251	0.00504	CcSEcCtD
Vildagliptin—Dizziness—Vincristine—sarcoma	0.0025	0.00502	CcSEcCtD
Vildagliptin—Infestation NOS—Doxorubicin—sarcoma	0.00249	0.005	CcSEcCtD
Vildagliptin—Infestation—Doxorubicin—sarcoma	0.00249	0.005	CcSEcCtD
Vildagliptin—Urticaria—Etoposide—sarcoma	0.00243	0.00488	CcSEcCtD
Vildagliptin—Hepatitis—Epirubicin—sarcoma	0.00241	0.00485	CcSEcCtD
Vildagliptin—Oedema peripheral—Epirubicin—sarcoma	0.00238	0.00478	CcSEcCtD
Vildagliptin—Connective tissue disorder—Epirubicin—sarcoma	0.00237	0.00476	CcSEcCtD
Vildagliptin—Headache—Vincristine—sarcoma	0.00236	0.00475	CcSEcCtD
Vildagliptin—Hepatobiliary disease—Doxorubicin—sarcoma	0.00235	0.00473	CcSEcCtD
Vildagliptin—Headache—Mitoxantrone—sarcoma	0.0023	0.00463	CcSEcCtD
Vildagliptin—Nausea—Vincristine—sarcoma	0.00224	0.00451	CcSEcCtD
Vildagliptin—Hepatitis—Doxorubicin—sarcoma	0.00223	0.00449	CcSEcCtD
Vildagliptin—Oedema peripheral—Doxorubicin—sarcoma	0.0022	0.00442	CcSEcCtD
Vildagliptin—Asthenia—Etoposide—sarcoma	0.00219	0.00441	CcSEcCtD
Vildagliptin—Connective tissue disorder—Doxorubicin—sarcoma	0.00219	0.00441	CcSEcCtD
Vildagliptin—Angiopathy—Epirubicin—sarcoma	0.00219	0.0044	CcSEcCtD
Vildagliptin—Nausea—Mitoxantrone—sarcoma	0.00218	0.00439	CcSEcCtD
Vildagliptin—Chills—Epirubicin—sarcoma	0.00216	0.00435	CcSEcCtD
Vildagliptin—Malnutrition—Epirubicin—sarcoma	0.0021	0.00422	CcSEcCtD
Vildagliptin—Diarrhoea—Etoposide—sarcoma	0.00209	0.0042	CcSEcCtD
Vildagliptin—Flatulence—Epirubicin—sarcoma	0.00207	0.00416	CcSEcCtD
Vildagliptin—Angiopathy—Doxorubicin—sarcoma	0.00202	0.00407	CcSEcCtD
Vildagliptin—Dizziness—Etoposide—sarcoma	0.00202	0.00406	CcSEcCtD
Vildagliptin—Chills—Doxorubicin—sarcoma	0.002	0.00403	CcSEcCtD
Vildagliptin—Malnutrition—Doxorubicin—sarcoma	0.00194	0.00391	CcSEcCtD
Vildagliptin—Headache—Etoposide—sarcoma	0.00191	0.00385	CcSEcCtD
Vildagliptin—Flatulence—Doxorubicin—sarcoma	0.00191	0.00385	CcSEcCtD
Vildagliptin—Nausea—Etoposide—sarcoma	0.00182	0.00365	CcSEcCtD
Vildagliptin—Arthralgia—Epirubicin—sarcoma	0.00179	0.00359	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.00178	0.00357	CcSEcCtD
Vildagliptin—Oedema—Epirubicin—sarcoma	0.00171	0.00344	CcSEcCtD
Vildagliptin—Infection—Epirubicin—sarcoma	0.0017	0.00342	CcSEcCtD
Vildagliptin—Nervous system disorder—Epirubicin—sarcoma	0.00168	0.00338	CcSEcCtD
Vildagliptin—Skin disorder—Epirubicin—sarcoma	0.00166	0.00335	CcSEcCtD
Vildagliptin—Hyperhidrosis—Epirubicin—sarcoma	0.00166	0.00333	CcSEcCtD
Vildagliptin—Arthralgia—Doxorubicin—sarcoma	0.00165	0.00332	CcSEcCtD
Vildagliptin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.00164	0.0033	CcSEcCtD
Vildagliptin—Oedema—Doxorubicin—sarcoma	0.00159	0.00319	CcSEcCtD
Vildagliptin—Infection—Doxorubicin—sarcoma	0.00158	0.00317	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00156	0.00314	CcSEcCtD
Vildagliptin—Nervous system disorder—Doxorubicin—sarcoma	0.00155	0.00313	CcSEcCtD
Vildagliptin—Skin disorder—Doxorubicin—sarcoma	0.00154	0.0031	CcSEcCtD
Vildagliptin—Hyperhidrosis—Doxorubicin—sarcoma	0.00153	0.00308	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Epirubicin—sarcoma	0.00148	0.00297	CcSEcCtD
Vildagliptin—Fatigue—Epirubicin—sarcoma	0.00148	0.00297	CcSEcCtD
Vildagliptin—Constipation—Epirubicin—sarcoma	0.00147	0.00295	CcSEcCtD
Vildagliptin—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.00144	0.0029	CcSEcCtD
Vildagliptin—Gastrointestinal disorder—Doxorubicin—sarcoma	0.00137	0.00275	CcSEcCtD
Vildagliptin—Fatigue—Doxorubicin—sarcoma	0.00137	0.00275	CcSEcCtD
Vildagliptin—Urticaria—Epirubicin—sarcoma	0.00136	0.00274	CcSEcCtD
Vildagliptin—Constipation—Doxorubicin—sarcoma	0.00136	0.00273	CcSEcCtD
Vildagliptin—Urticaria—Doxorubicin—sarcoma	0.00126	0.00253	CcSEcCtD
Vildagliptin—Asthenia—Epirubicin—sarcoma	0.00123	0.00247	CcSEcCtD
Vildagliptin—Diarrhoea—Epirubicin—sarcoma	0.00117	0.00236	CcSEcCtD
Vildagliptin—Asthenia—Doxorubicin—sarcoma	0.00114	0.00229	CcSEcCtD
Vildagliptin—Dizziness—Epirubicin—sarcoma	0.00113	0.00228	CcSEcCtD
Vildagliptin—Diarrhoea—Doxorubicin—sarcoma	0.00108	0.00218	CcSEcCtD
Vildagliptin—Headache—Epirubicin—sarcoma	0.00107	0.00216	CcSEcCtD
Vildagliptin—Dizziness—Doxorubicin—sarcoma	0.00105	0.00211	CcSEcCtD
Vildagliptin—Nausea—Epirubicin—sarcoma	0.00102	0.00205	CcSEcCtD
Vildagliptin—Headache—Doxorubicin—sarcoma	0.000993	0.002	CcSEcCtD
Vildagliptin—Nausea—Doxorubicin—sarcoma	0.000942	0.00189	CcSEcCtD
